25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CBAV (Clinica Baviera) Stock Analysis
Buy, Hold or Sell?

Let's analyze Clinica Baviera together

I guess you are interested in Clinica Baviera. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Clinica Baviera’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Clinica Baviera’s Price Targets

I'm going to help you getting a better view of Clinica Baviera. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Clinica Baviera

I send you an email if I find something interesting about Clinica Baviera.

1. Quick Overview

1.1. Quick analysis of Clinica Baviera (30 sec.)










1.2. What can you expect buying and holding a share of Clinica Baviera? (30 sec.)

How much money do you get?

How much money do you get?
€0.09
When do you have the money?
1 year
How often do you get paid?
72.5%

What is your share worth?

Current worth
€6.96
Expected worth in 1 year
€7.50
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
€0.61
Return On Investment
1.4%

For what price can you sell your share?

Current Price per Share
€43.50
Expected price per share
€38.10 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Clinica Baviera (5 min.)




Live pricePrice per Share (EOD)
€43.50
Intrinsic Value Per Share
€25.57 - €37.32
Total Value Per Share
€32.53 - €44.28

2.2. Growth of Clinica Baviera (5 min.)




Is Clinica Baviera growing?

Current yearPrevious yearGrowGrow %
How rich?$130.2m$103.7m$6m5.5%

How much money is Clinica Baviera making?

Current yearPrevious yearGrowGrow %
Making money$11.8m$10.7m$1.1m9.5%
Net Profit Margin14.3%15.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Clinica Baviera (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#59 / 127

Most Revenue
#54 / 127

Most Profit
#31 / 127
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Clinica Baviera?

Welcome investor! Clinica Baviera's management wants to use your money to grow the business. In return you get a share of Clinica Baviera.

First you should know what it really means to hold a share of Clinica Baviera. And how you can make/lose money.

Speculation

The Price per Share of Clinica Baviera is €43.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clinica Baviera.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clinica Baviera, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €6.96. Based on the TTM, the Book Value Change Per Share is €0.13 per quarter. Based on the YOY, the Book Value Change Per Share is €0.44 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clinica Baviera.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps0.942.2%0.741.7%0.541.2%0.601.4%0.541.2%0.360.8%
Usd Book Value Change Per Share0.952.2%0.160.4%0.511.2%0.280.6%0.290.7%0.170.4%
Usd Dividend Per Share0.040.1%0.020.0%0.010.0%0.110.3%0.190.4%0.180.4%
Usd Total Gains Per Share0.992.3%0.180.4%0.521.2%0.390.9%0.481.1%0.350.8%
Usd Price Per Share41.51-37.59-26.45-28.74-24.42-18.07-
Price to Earnings Ratio11.04-15.62-13.61-13.55-13.62-18.32-
Price-to-Total Gains Ratio41.89-46.88-24.32-32.38-39.14-82.18-
Price to Book Ratio5.10-5.57-4.76-4.79-4.83-5.77-
Price-to-Total Gains Ratio41.89-46.88-24.32-32.38-39.14-82.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share50.8602
Number of shares19
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.19
Usd Book Value Change Per Share0.160.29
Usd Total Gains Per Share0.180.48
Gains per Quarter (19 shares)3.409.19
Gains per Year (19 shares)13.5936.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12124152227
232418304464
3536324466101
4748465988138
58606074110175
610727489132212
7118488104154249
81396102118176286
915108116133198323
1016119130148220360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%66.01.00.098.5%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%14.06.00.070.0%24.011.05.060.0%34.019.014.050.7%
Dividend per Share2.00.02.050.0%9.00.03.075.0%15.00.05.075.0%29.00.011.072.5%43.00.024.064.2%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%32.04.04.080.0%48.06.013.071.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Clinica Baviera compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8150.134+506%0.436+87%0.240+239%0.247+230%0.143+470%
Book Value Per Share--6.9605.823+20%4.812+45%5.186+34%4.342+60%2.915+139%
Current Ratio--1.1890.913+30%1.363-13%1.183+1%1.232-3%0.972+22%
Debt To Asset Ratio--0.5160.559-8%0.507+2%0.511+1%0.549-6%0.570-9%
Debt To Equity Ratio--1.0791.301-17%1.055+2%1.125-4%1.312-18%1.432-25%
Dividend Per Share--0.0330.018+78%0.005+615%0.096-66%0.166-80%0.158-79%
Enterprise Value--449261350.000430624768.625+4%378547815.325+19%362932588.338+24%299559284.918+50%216641125.277+107%
Eps--0.8040.631+27%0.460+75%0.514+56%0.462+74%0.304+164%
Ev To Sales Ratio--1.4001.581-11%1.646-15%1.538-9%1.427-2%1.354+3%
Free Cash Flow Per Share--1.1950.650+84%0.481+148%0.573+109%0.561+113%0.403+197%
Free Cash Flow To Equity Per Share--1.1950.080+1395%0.328+264%0.173+590%0.187+539%0.165+623%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--37.319----------
Intrinsic Value_10Y_min--25.570----------
Intrinsic Value_1Y_max--2.504----------
Intrinsic Value_1Y_min--1.784----------
Intrinsic Value_3Y_max--8.465----------
Intrinsic Value_3Y_min--6.065----------
Intrinsic Value_5Y_max--15.562----------
Intrinsic Value_5Y_min--11.088----------
Market Cap696247950.000+18%568202350.000518692018.625+10%419431112.575+35%415823519.504+37%349518866.818+63%256478767.002+122%
Net Profit Margin--0.1600.143+12%0.156+3%0.148+9%0.148+8%0.118+35%
Operating Margin---0.148-100%0.217-100%0.189-100%0.199-100%0.161-100%
Operating Ratio--0.7710.909-15%0.871-12%1.028-25%1.075-28%1.194-35%
Pb Ratio6.250+18%5.1015.572-8%4.758+7%4.789+7%4.835+5%5.770-12%
Pe Ratio13.524+18%11.03615.618-29%13.614-19%13.555-19%13.618-19%18.319-40%
Price Per Share43.500+18%35.50032.150+10%22.625+57%24.583+44%20.885+70%15.455+130%
Price To Free Cash Flow Ratio9.103+18%7.42917.776-58%12.838-42%18.565-60%14.822-50%26.619-72%
Price To Total Gains Ratio51.331+18%41.89046.875-11%24.323+72%32.378+29%39.136+7%82.177-49%
Quick Ratio--0.1820.885-79%1.745-90%1.463-88%1.477-88%1.182-85%
Return On Assets--0.0560.048+17%0.051+10%0.049+14%0.049+14%0.044+26%
Return On Equity--0.1170.109+7%0.104+12%0.107+9%0.113+3%0.106+11%
Total Gains Per Share--0.8470.153+454%0.441+92%0.337+152%0.414+105%0.301+182%
Usd Book Value--130246541.600109769172.800+19%103740330.673+26%102444078.776+27%84929044.806+53%56635878.963+130%
Usd Book Value Change Per Share--0.9520.157+506%0.510+87%0.281+239%0.289+230%0.167+470%
Usd Book Value Per Share--8.1386.809+20%5.626+45%6.063+34%5.077+60%3.408+139%
Usd Dividend Per Share--0.0380.022+78%0.005+615%0.113-66%0.195-80%0.184-79%
Usd Enterprise Value--525276370.420503486479.476+4%442598105.678+19%424340782.284+24%350244715.926+50%253296803.674+107%
Usd Eps--0.9400.738+27%0.538+75%0.601+56%0.540+74%0.356+164%
Usd Free Cash Flow--22357442.40012239185.600+83%10207879.488+119%11213408.246+99%10864401.656+106%6995978.147+220%
Usd Free Cash Flow Per Share--1.3970.760+84%0.562+148%0.670+109%0.655+113%0.471+197%
Usd Free Cash Flow To Equity Per Share--1.3970.093+1395%0.383+264%0.202+590%0.219+539%0.193+623%
Usd Market Cap814053103.140+18%664342187.620606454708.176+10%490398856.823+35%486180859.004+37%408657459.083+63%299874974.379+122%
Usd Price Per Share50.860+18%41.50737.590+10%26.453+57%28.743+44%24.419+70%18.070+130%
Usd Profit--15048773.20011885502.600+27%10750772.954+40%10470035.563+44%9223215.493+63%6011961.977+150%
Usd Revenue--93788547.20081204886.050+15%67795463.077+38%69684680.601+35%60420838.545+55%45358491.284+107%
Usd Total Gains Per Share--0.9910.179+454%0.516+92%0.393+152%0.484+105%0.352+182%
 EOD+4 -4MRQTTM+33 -5YOY+30 -83Y+30 -85Y+30 -810Y+32 -6

3.3 Fundamental Score

Let's check the fundamental score of Clinica Baviera based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.524
Price to Book Ratio (EOD)Between0-16.250
Net Profit Margin (MRQ)Greater than00.160
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.182
Current Ratio (MRQ)Greater than11.189
Debt to Asset Ratio (MRQ)Less than10.516
Debt to Equity Ratio (MRQ)Less than11.079
Return on Equity (MRQ)Greater than0.150.117
Return on Assets (MRQ)Greater than0.050.056
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Clinica Baviera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.345
Ma 20Greater thanMa 5041.195
Ma 50Greater thanMa 10039.417
Ma 100Greater thanMa 20036.445
OpenGreater thanClose43.900
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Clinica Baviera

ClΓ­nica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, lasek, and intraocular lenses treatments. The company was formerly known as ClΓ­nica OftalmolΓ³gica Baviera, S.L. and changed its name to ClΓ­nica Baviera, S.A. in 2000. ClΓ­nica Baviera, S.A. was incorporated in 1992 and is headquartered in Madrid, Spain. ClΓ­nica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

Fundamental data was last updated by Penke on 2025-06-27 20:43:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Clinica Baviera earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of 16.0%Β means thatΒ €0.16 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clinica Baviera:

  • The MRQ is 16.0%. The company is making a huge profit. +2
  • The TTM is 14.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.0%TTM14.3%+1.8%
TTM14.3%YOY15.6%-1.3%
TTM14.3%5Y14.8%-0.5%
5Y14.8%10Y11.8%+3.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ16.0%-5.0%+21.0%
TTM14.3%-5.8%+20.1%
YOY15.6%-9.0%+24.6%
3Y14.8%-8.5%+23.3%
5Y14.8%-4.9%+19.7%
10Y11.8%-1.8%+13.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Clinica Baviera is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • 5.6% Return on Assets means thatΒ Clinica Baviera generatedΒ €0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clinica Baviera:

  • The MRQ is 5.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 4.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.6%TTM4.8%+0.8%
TTM4.8%YOY5.1%-0.3%
TTM4.8%5Y4.9%-0.1%
5Y4.9%10Y4.4%+0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6%-0.7%+6.3%
TTM4.8%-0.8%+5.6%
YOY5.1%-1.3%+6.4%
3Y4.9%-1.4%+6.3%
5Y4.9%-0.1%+5.0%
10Y4.4%0.1%+4.3%
4.3.1.3. Return on Equity

Shows how efficient Clinica Baviera is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • 11.7% Return on Equity means Clinica Baviera generated €0.12Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clinica Baviera:

  • The MRQ is 11.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.7%TTM10.9%+0.8%
TTM10.9%YOY10.4%+0.5%
TTM10.9%5Y11.3%-0.4%
5Y11.3%10Y10.6%+0.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-0.8%+12.5%
TTM10.9%-0.8%+11.7%
YOY10.4%-2.0%+12.4%
3Y10.7%-1.7%+12.4%
5Y11.3%-1.1%+12.4%
10Y10.6%-1.4%+12.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Clinica Baviera.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Clinica Baviera is operatingΒ .

  • Measures how much profit Clinica Baviera makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clinica Baviera:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM14.8%-14.8%
TTM14.8%YOY21.7%-7.0%
TTM14.8%5Y19.9%-5.1%
5Y19.9%10Y16.1%+3.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.8%-4.8%
TTM14.8%-10.7%+25.5%
YOY21.7%-8.5%+30.2%
3Y18.9%-1.7%+20.6%
5Y19.9%3.2%+16.7%
10Y16.1%4.0%+12.1%
4.3.2.2. Operating Ratio

Measures how efficient Clinica Baviera is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 0.77 means that the operating costs are €0.77 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Clinica Baviera:

  • The MRQ is 0.771. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.909. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.771TTM0.909-0.138
TTM0.909YOY0.871+0.038
TTM0.9095Y1.075-0.166
5Y1.07510Y1.194-0.119
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7711.375-0.604
TTM0.9091.302-0.393
YOY0.8711.292-0.421
3Y1.0281.284-0.256
5Y1.0751.277-0.202
10Y1.1941.192+0.002
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Clinica Baviera.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Clinica Baviera is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 1.19Β means the company has €1.19 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Clinica Baviera:

  • The MRQ is 1.189. The company is just able to pay all its short-term debts.
  • The TTM is 0.913. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.189TTM0.913+0.277
TTM0.913YOY1.363-0.450
TTM0.9135Y1.232-0.320
5Y1.23210Y0.972+0.260
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1892.037-0.848
TTM0.9132.055-1.142
YOY1.3632.374-1.011
3Y1.1832.414-1.231
5Y1.2322.552-1.320
10Y0.9722.974-2.002
4.4.3.2. Quick Ratio

Measures if Clinica Baviera is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 0.18Β means the company can pay off €0.18 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clinica Baviera:

  • The MRQ is 0.182. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.885. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.885-0.703
TTM0.885YOY1.745-0.859
TTM0.8855Y1.477-0.592
5Y1.47710Y1.182+0.295
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1821.084-0.902
TTM0.8851.132-0.247
YOY1.7451.354+0.391
3Y1.4631.538-0.075
5Y1.4771.803-0.326
10Y1.1822.090-0.908
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Clinica Baviera.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Clinica BavieraΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Clinica Baviera to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.52Β means that Clinica Baviera assets areΒ financed with 51.6% credit (debt) and the remaining percentage (100% - 51.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Clinica Baviera:

  • The MRQ is 0.516. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.559. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.516TTM0.559-0.042
TTM0.559YOY0.507+0.051
TTM0.5595Y0.549+0.010
5Y0.54910Y0.570-0.021
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5160.385+0.131
TTM0.5590.432+0.127
YOY0.5070.390+0.117
3Y0.5110.389+0.122
5Y0.5490.410+0.139
10Y0.5700.454+0.116
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Clinica Baviera is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 107.9% means that company has €1.08 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clinica Baviera:

  • The MRQ is 1.079. The company is able to pay all its debts with equity. +1
  • The TTM is 1.301. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.079TTM1.301-0.222
TTM1.301YOY1.055+0.246
TTM1.3015Y1.312-0.011
5Y1.31210Y1.432-0.120
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0790.604+0.475
TTM1.3010.612+0.689
YOY1.0550.589+0.466
3Y1.1250.702+0.423
5Y1.3120.674+0.638
10Y1.4320.657+0.775
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Clinica Baviera generates.

  • Above 15 is considered overpriced butΒ always compareΒ Clinica Baviera to theΒ Diagnostics & Research industry mean.
  • A PE ratio of 11.04 means the investor is paying €11.04Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clinica Baviera:

  • The EOD is 13.524. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.036. Based on the earnings, the company is underpriced. +1
  • The TTM is 15.618. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD13.524MRQ11.036+2.487
MRQ11.036TTM15.618-4.581
TTM15.618YOY13.614+2.003
TTM15.6185Y13.618+2.000
5Y13.61810Y18.319-4.701
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD13.524-0.557+14.081
MRQ11.036-0.732+11.768
TTM15.618-0.475+16.093
YOY13.614-0.128+13.742
3Y13.555-0.087+13.642
5Y13.6185.675+7.943
10Y18.3197.829+10.490
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clinica Baviera:

  • The EOD is 9.103. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.429. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 17.776. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.103MRQ7.429+1.674
MRQ7.429TTM17.776-10.348
TTM17.776YOY12.838+4.938
TTM17.7765Y14.822+2.955
5Y14.82210Y26.619-11.797
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD9.103-1.022+10.125
MRQ7.429-1.081+8.510
TTM17.776-0.557+18.333
YOY12.838-1.055+13.893
3Y18.565-0.440+19.005
5Y14.822-0.670+15.492
10Y26.619-0.655+27.274
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Clinica Baviera is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 5.10 means the investor is paying €5.10Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Clinica Baviera:

  • The EOD is 6.250. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.101. Based on the equity, the company is overpriced. -1
  • The TTM is 5.572. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.250MRQ5.101+1.149
MRQ5.101TTM5.572-0.472
TTM5.572YOY4.758+0.814
TTM5.5725Y4.835+0.738
5Y4.83510Y5.770-0.935
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD6.2502.088+4.162
MRQ5.1012.072+3.029
TTM5.5722.188+3.384
YOY4.7582.305+2.453
3Y4.7892.476+2.313
5Y4.8353.475+1.360
10Y5.7704.360+1.410
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets230,339
Total Liabilities118,941
Total Stockholder Equity110,267
 As reported
Total Liabilities 118,941
Total Stockholder Equity+ 110,267
Total Assets = 230,339

Assets

Total Assets230,339
Total Current Assets63,125
Long-term Assets167,214
Total Current Assets
Cash And Cash Equivalents 53,443
Net Receivables 9,682
Total Current Assets  (as reported)63,125
Total Current Assets  (calculated)63,125
+/-0
Long-term Assets
Property Plant Equipment 123,740
Long-term Assets  (as reported)167,214
Long-term Assets  (calculated)123,740
+/- 43,474

Liabilities & Shareholders' Equity

Total Current Liabilities53,069
Long-term Liabilities65,872
Total Stockholder Equity110,267
Total Current Liabilities
Accounts payable 21,961
Other Current Liabilities 17,787
Total Current Liabilities  (as reported)53,069
Total Current Liabilities  (calculated)39,748
+/- 13,321
Long-term Liabilities
Long term Debt 6,344
Capital Lease Obligations Min Short Term Debt54,781
Long-term Liabilities Other 4,747
Long-term Liabilities  (as reported)65,872
Long-term Liabilities  (calculated)65,872
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)110,267
Total Stockholder Equity (calculated)0
+/- 110,267
Other
Common Stock Shares Outstanding 15,993
Net Invested Capital 116,611
Net Working Capital 10,056
Property Plant and Equipment Gross 123,740



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-06-302009-03-312008-12-312008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312005-09-30
> Total Assets 
30,112
43,392
0
42,865
0
45,248
0
71,251
64,119
0
63,335
58,753
0
59,908
56,842
0
58,831
0
57,856
0
56,763
0
51,668
0
49,603
0
48,278
0
46,664
0
49,038
0
47,550
0
46,380
0
49,707
0
46,767
48,692
49,321
0
53,992
0
54,174
54,470
55,830
94,834
95,416
97,310
101,564
109,783
109,228
113,627
120,922
129,510
127,671
130,918
133,809
142,211
142,356
143,352
149,080
170,190
170,190
175,160
178,642
193,944
203,014
202,738
211,953
230,339
230,339211,953202,738203,014193,944178,642175,160170,190170,190149,080143,352142,356142,211133,809130,918127,671129,510120,922113,627109,228109,783101,56497,31095,41694,83455,83054,47054,174053,992049,32148,69246,767049,707046,380047,550049,038046,664048,278049,603051,668056,763057,856058,831056,84259,908058,75363,335064,11971,251045,248042,865043,39230,112
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
17,254
0
19,650
16,398
0
18,485
0
16,048
0
15,162
0
12,597
0
16,946
0
16,735
0
15,303
0
16,679
0
14,905
0
15,007
0
18,032
0
13,998
15,474
15,322
0
15,586
0
14,400
13,233
12,695
13,987
11,508
10,893
11,174
21,072
20,898
26,833
31,378
37,703
36,472
39,399
37,923
49,018
47,174
47,452
44,609
47,670
47,670
51,246
57,741
67,595
59,324
41,268
47,981
63,125
63,12547,98141,26859,32467,59557,74151,24647,67047,67044,60947,45247,17449,01837,92339,39936,47237,70331,37826,83320,89821,07211,17410,89311,50813,98712,69513,23314,400015,586015,32215,47413,998018,032015,007014,905016,679015,303016,735016,946012,597015,162016,048018,485016,39819,650017,25400000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
13,964
0
16,556
13,571
0
15,851
0
13,852
0
12,674
0
9,404
0
15,114
0
12,726
0
10,287
0
2,761
0
3,016
0
4,587
0
5,815
0
4,026
13,486
5,077
0
5,677
0
4,487
10,648
3,911
10,793
5,202
7,882
3,921
17,124
7,958
22,463
10,822
32,565
14,852
35,304
9,801
44,070
14,622
42,582
19,173
10,984
10,984
46,409
8,306
60,400
7,030
32,278
10,141
53,443
53,44310,14132,2787,03060,4008,30646,40910,98410,98419,17342,58214,62244,0709,80135,30414,85232,56510,82222,4637,95817,1243,9217,8825,20210,7933,91110,6484,48705,67705,07713,4864,02605,81504,58703,01602,761010,287012,726015,11409,404012,674013,852015,851013,57116,556013,96400000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,823
0
0
0
10,579
0
0
0
10,258
0
9,358
0
8,525
0
9,944
0
7,799
0
8,199
0
6,538
0
6,134
0
5,893
0
2,994
0
2,567
0
8,567
0
16,114
0
17,064
0
22,471
0
27,471
6,354
19,817
30,459
30,459
0
42,934
0
42,350
0
28,440
0
028,440042,350042,934030,45930,45919,8176,35427,471022,471017,064016,11408,56702,56702,99405,89306,13406,53808,19907,79909,94408,52509,358010,25800010,5790006,8230000000000000000000000
       Net Receivables 
1,260
2,205
0
3,614
0
2,272
0
4,063
2,814
0
4,000
2,721
0
2,256
1,923
0
1,694
0
1,347
0
1,507
0
1,502
0
898
0
1,282
0
719
0
1,288
0
653
0
609
0
1,077
0
1,069
1,988
680
0
1,350
0
1,216
2,585
1,008
3,194
1,443
3,011
2,656
3,948
2,041
4,370
2,266
2,344
2,291
4,095
3,363
4,948
2,466
4,870
2,844
3,062
3,356
4,837
2,952
7,195
2,903
8,990
4,815
9,682
9,6824,8158,9902,9037,1952,9524,8373,3563,0622,8444,8702,4664,9483,3634,0952,2912,3442,2664,3702,0413,9482,6563,0111,4433,1941,0082,5851,21601,35006801,9881,06901,0770609065301,288071901,282089801,50201,50701,34701,69401,9232,25602,7214,00002,8144,06302,27203,61402,2051,260
       Inventory 
218
492
0
553
0
679
0
753
594
0
527
554
0
698
833
0
764
0
733
0
736
0
1,507
0
874
0
2,400
0
3,811
0
2,223
0
1,546
0
847
0
705
0
722
0
668
0
943
0
1,255
0
989
0
969
0
1,198
0
1,428
0
1,642
1,835
1,835
0
1,933
0
2,091
0
2,162
2,428
2,428
0
2,473
0
2,732
0
3,283
0
03,28302,73202,47302,4282,4282,16202,09101,93301,8351,8351,64201,42801,1980969098901,2550943066807220705084701,54602,22303,81102,400087401,507073607330764083369805545270594753067905530492218
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
41,499
0
40,258
40,444
0
40,346
0
41,808
0
41,601
0
39,071
0
32,657
0
31,543
0
31,361
0
32,359
0
32,645
0
31,372
0
31,675
0
32,769
33,218
33,999
0
38,406
0
39,774
41,238
43,135
80,847
83,908
86,417
90,390
88,711
88,330
86,794
89,544
91,806
91,199
91,519
95,886
93,192
95,182
95,900
1,011
122,520
122,520
123,914
120,901
126,349
143,690
161,471
163,972
167,214
167,214163,972161,471143,690126,349120,901123,914122,520122,5201,01195,90095,18293,19295,88691,51991,19991,80689,54486,79488,33088,71190,39086,41783,90880,84743,13541,23839,774038,406033,99933,21832,769031,675031,372032,645032,359031,361031,543032,657039,071041,601041,808040,346040,44440,258041,49900000000000
       Property Plant Equipment 
8,488
12,545
0
17,559
0
20,983
0
25,843
26,676
0
24,371
21,794
0
20,681
20,386
0
19,831
0
21,401
0
21,018
0
21,143
0
16,569
0
16,646
0
16,502
0
17,268
0
17,416
0
16,477
0
16,685
0
18,175
18,527
18,791
0
23,002
0
24,095
25,583
27,479
28,332
66,430
68,971
72,939
71,276
70,882
69,318
71,403
73,362
72,347
72,391
77,253
74,396
76,173
76,835
86,079
90,441
90,441
92,735
99,060
102,546
104,770
119,074
122,662
123,740
123,740122,662119,074104,770102,54699,06092,73590,44190,44186,07976,83576,17374,39677,25372,39172,34773,36271,40369,31870,88271,27672,93968,97166,43028,33227,47925,58324,095023,002018,79118,52718,175016,685016,477017,416017,268016,502016,646016,569021,143021,018021,401019,831020,38620,681021,79424,371026,67625,843020,983017,559012,5458,488
       Goodwill 
81
9,518
0
9,485
0
9,299
0
23,803
19,544
0
18,645
17,990
0
17,946
17,892
0
17,927
0
17,497
0
17,597
0
14,393
0
12,869
0
12,785
0
12,785
0
12,785
0
12,785
0
12,785
0
12,890
0
12,785
0
13,299
0
13,458
0
13,458
0
13,458
0
14,652
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
14,616
14,616
0
14,616
0
14,616
0
28,308
0
028,308014,616014,616014,61614,61614,616014,616014,616014,616014,616014,616014,616014,652013,458013,458013,458013,299012,785012,890012,785012,785012,785012,785012,785012,869014,393017,597017,497017,927017,89217,946017,99018,645019,54423,80309,29909,48509,51881
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,509
0
0
0
0
0
1,733
0
2,437
1,772
2,511
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000442,5111,7722,43701,733000001,509000000000000000000000000000000000000000
       Intangible Assets 
175
9,633
0
9,620
0
9,574
0
23,885
19,795
0
18,913
249
0
172
104
0
17,989
0
63
0
219
0
205
0
211
0
162
0
123
0
123
0
197
0
300
0
305
0
341
13,182
377
0
508
0
486
13,922
468
50,078
350
14,935
312
0
272
0
564
0
1,266
0
998
0
1,238
15,888
461
1,346
1,346
0
2,747
0
3,734
0
8,731
0
08,73103,73402,74701,3461,34646115,8881,238099801,26605640272031214,93535050,07846813,9224860508037713,182341030503000197012301230162021102050219063017,9890104172024918,913019,79523,88509,57409,62009,633175
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
954
0
1,031
977
0
2,526
0
1,534
0
1,454
0
6,823
0
1,210
0
10,924
0
1,522
0
10,603
0
9,358
0
8,525
0
9,944
0
7,799
1,509
8,199
0
6,538
0
6,134
1,733
5,893
2,437
2,994
2,511
2,808
2,538
8,567
2,567
16,314
2,982
17,064
2,964
22,671
3,054
27,471
3,177
-84,667
12,745
30,459
2,113
42,934
4,605
58,810
4,205
56,882
0
056,8824,20558,8104,60542,9342,11330,45912,745-84,6673,17727,4713,05422,6712,96417,0642,98216,3142,5678,5672,5382,8082,5112,9942,4375,8931,7336,13406,53808,1991,5097,79909,94408,52509,358010,60301,522010,92401,21006,82301,45401,53402,52609771,031095400000000000
> Total Liabilities 
15,775
23,901
0
28,089
0
25,370
0
52,650
45,095
0
43,180
37,887
0
36,887
34,438
0
34,413
0
34,029
0
33,778
0
30,811
0
27,007
0
22,933
0
26,964
0
28,835
0
27,388
0
25,067
0
25,748
0
28,192
27,505
29,249
0
29,114
0
30,229
29,495
27,067
63,643
70,248
70,769
70,760
76,878
75,343
75,100
76,017
76,848
75,708
73,399
78,415
75,721
76,455
72,897
40,697
93,948
93,948
93,445
86,367
89,266
122,340
117,634
113,593
118,941
118,941113,593117,634122,34089,26686,36793,44593,94893,94840,69772,89776,45575,72178,41573,39975,70876,84876,01775,10075,34376,87870,76070,76970,24863,64327,06729,49530,229029,114029,24927,50528,192025,748025,067027,388028,835026,964022,933027,007030,811033,778034,029034,413034,43836,887037,88743,180045,09552,650025,370028,089023,90115,775
   > Total Current Liabilities 
8,848
11,145
0
15,635
0
14,295
0
22,357
18,974
0
17,398
16,013
0
15,821
17,116
0
15,618
0
16,888
0
13,896
0
16,691
0
11,531
0
14,517
0
13,062
0
15,479
0
11,491
0
13,904
0
12,659
0
15,950
11,129
13,466
0
18,593
0
18,977
13,427
18,431
15,353
29,694
15,631
27,690
15,454
27,765
18,607
32,348
21,808
33,990
23,797
35,222
28,077
37,467
29,392
41,039
41,941
41,941
35,246
45,266
42,671
82,823
51,700
50,700
53,069
53,06950,70051,70082,82342,67145,26635,24641,94141,94141,03929,39237,46728,07735,22223,79733,99021,80832,34818,60727,76515,45427,69015,63129,69415,35318,43113,42718,977018,593013,46611,12915,950012,659013,904011,491015,479013,062014,517011,531016,691013,896016,888015,618017,11615,821016,01317,398018,97422,357014,295015,635011,1458,848
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
4,533
0
0
4,813
0
0
0
5,837
0
3,193
0
6,255
0
3,159
0
5,307
0
3,016
0
4,354
0
2,367
0
4,245
0
2,192
0
5,517
16,376
3,593
18,151
5,516
14,748
6,093
0
5,649
0
8,840
0
11,851
0
6,105
0
13,131
0
5,083
0
11,564
0
3,792
0
9,841
2,011
2,011
0
10,655
0
1,514
0
0
0
0001,514010,65502,0112,0119,84103,792011,56405,083013,13106,105011,85108,84005,64906,09314,7485,51618,1513,59316,3765,51702,19204,24502,36704,35403,01605,30703,15906,25503,19305,8370004,813004,53300000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,533
16,376
18,151
18,151
5,516
14,748
6,093
0
5,649
0
8,840
0
4,417
0
6,105
0
5,876
0
5,083
0
4,203
0
3,792
0
2,006
0
2,011
0
2,115
0
1,514
0
2,014
0
02,01401,51402,11502,01102,00603,79204,20305,08305,87606,10504,41708,84005,64906,09314,7485,51618,15118,15116,37616,53300000000000000000000000000000000000000
       Accounts payable 
1,689
2,421
0
4,634
0
6,276
0
12,402
8,106
0
7,118
6,780
0
2,566
6,581
0
6,126
0
7,086
0
2,831
0
6,862
0
2,693
0
6,862
0
5,719
0
6,836
0
4,281
0
6,747
0
3,671
0
5,982
6,817
2,957
0
8,180
0
3,346
7,741
7,025
8,854
3,553
9,019
8,151
8,924
2,714
11,419
9,937
12,042
4,490
10,265
12,981
12,886
5,972
12,505
15,622
6,710
6,710
14,399
15,524
17,540
7,479
20,459
10,062
21,961
21,96110,06220,4597,47917,54015,52414,3996,7106,71015,62212,5055,97212,88612,98110,2654,49012,0429,93711,4192,7148,9248,1519,0193,5538,8547,0257,7413,34608,18002,9576,8175,98203,67106,74704,28106,83605,71906,86202,69306,86202,83107,08606,12606,5812,56606,7807,11808,10612,40206,27604,63402,4211,689
       Other Current Liabilities 
4,358
5,780
0
8,057
0
4,819
0
6,045
6,470
0
6,321
4,517
0
11,989
5,555
0
3,346
0
3,039
0
999
0
2,769
0
4,384
0
1,901
0
986
0
4,286
0
1,133
0
2,631
0
-39
0
3,789
4,312
-111
0
3,634
0
-2,167
494
4,165
6,499
-1,405
1,402
4,690
6,530
15,742
7,188
5,057
9,766
18,335
4,910
7,754
6,135
27,703
7,260
13,628
33,220
4,523
11,601
12,803
-3,753
62,877
20,128
37,031
17,787
17,78737,03120,12862,877-3,75312,80311,6014,52333,22013,6287,26027,7036,1357,7544,91018,3359,7665,0577,18815,7426,5304,6901,402-1,4056,4994,165494-2,16703,6340-1114,3123,7890-3902,63101,13304,286098601,90104,38402,769099903,03903,34605,55511,98904,5176,32106,4706,04504,81908,05705,7804,358
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
21,874
0
21,066
17,322
0
18,795
0
17,141
0
19,882
0
14,120
0
15,476
0
8,416
0
13,902
0
13,356
0
15,897
0
11,164
0
13,089
0
12,242
16,376
15,783
0
10,521
0
11,252
16,068
8,635
48,290
40,554
55,138
43,070
61,424
47,578
56,493
43,669
55,040
41,718
49,602
43,193
47,644
38,988
43,505
40,697
52,007
52,007
58,199
41,101
46,595
39,239
65,934
62,893
65,872
65,87262,89365,93439,23946,59541,10158,19952,00752,00740,69743,50538,98847,64443,19349,60241,71855,04043,66956,49347,57861,42443,07055,13840,55448,2908,63516,06811,252010,521015,78316,37612,242013,089011,164015,897013,356013,90208,416015,476014,120019,882017,141018,795017,32221,066021,87400000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,526
0
2,516
0
47,674
0
0
0
0
0
0
0
000000047,67402,516047,526000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
-4,533
0
0
-4,813
0
0
0
-5,837
0
-3,193
0
-6,255
0
-3,159
0
-5,307
0
-3,016
0
-4,354
0
-2,367
0
-4,245
0
-2,192
0
-5,517
-16,376
-3,593
-18,151
-5,516
-14,748
-6,093
0
-5,649
35,851
-8,840
38,285
29,368
40,242
-6,105
38,598
25,211
40,118
-5,083
37,573
29,265
38,119
-3,792
38,383
25,571
-2,011
-2,011
43,537
34,098
44,478
-1,514
53,461
54,132
54,781
54,78154,13253,461-1,51444,47834,09843,537-2,011-2,01125,57138,383-3,79238,11929,26537,573-5,08340,11825,21138,598-6,10540,24229,36838,285-8,84035,851-5,6490-6,093-14,748-5,516-18,151-3,593-16,376-5,5170-2,1920-4,2450-2,3670-4,3540-3,0160-5,3070-3,1590-6,2550-3,1930-5,837000-4,81300-4,53300000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
175
0
86
0
83
0
1
0
96
0
140
645
101
0
100
0
0
0
101
0
100
278
4,417
0
4,747
4,74704,4172781000101000100010164514009601083086017500000000000000000000000000000000000000000000000
> Total Stockholder Equity
14,225
19,336
19,490
14,500
14,776
19,707
19,878
18,447
19,088
19,024
20,249
20,866
20,866
22,990
22,412
22,404
24,418
24,418
23,719
23,827
22,987
0
21,354
20,856
22,489
0
24,949
25,346
19,328
19,700
19,903
20,203
19,836
20,162
21,070
21,312
23,851
0
18,504
21,076
19,840
19,840
24,584
24,879
23,648
24,705
28,486
30,924
24,887
26,341
30,592
32,674
33,647
38,193
44,492
52,110
51,470
56,934
54,604
65,443
65,095
69,540
67,344
75,306
75,306
80,719
90,996
103,110
79,043
83,803
96,920
110,267
110,26796,92083,80379,043103,11090,99680,71975,30675,30667,34469,54065,09565,44354,60456,93451,47052,11044,49238,19333,64732,67430,59226,34124,88730,92428,48624,70523,64824,87924,58419,84019,84021,07618,504023,85121,31221,07020,16219,83620,20319,90319,70019,32825,34624,949022,48920,85621,354022,98723,82723,71924,41824,41822,40422,41222,99020,86620,86620,24919,02419,08818,44719,87819,70714,77614,50019,49019,33614,225
   Common Stock
1,626
1,631
0
1,631
0
1,631
0
1,631
1,631
0
1,631
1,631
0
1,631
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
21,076
1,631
0
1,631
0
1,631
24,705
1,631
30,924
1,631
26,341
1,631
32,674
1,631
38,193
1,631
1,631
1,631
56,934
1,631
65,443
1,631
69,540
1,631
1,631
1,631
80,719
1,631
0
1,631
0
1,631
0
01,63101,63101,63180,7191,6311,6311,63169,5401,63165,4431,63156,9341,6311,6311,63138,1931,63132,6741,63126,3411,63130,9241,63124,7051,63101,63101,63121,0761,63101,63101,63101,63101,63101,63101,63101,63101,63101,63101,63101,63101,6311,63101,6311,63101,6311,63101,63101,63101,6311,626
   Retained Earnings 
7,725
13,000
0
7,308
0
13,163
0
11,922
12,463
0
13,540
1,861
0
3,975
5,220
0
18,153
0
3,482
0
-22
0
-88
0
3,580
0
4,887
0
2,265
0
4,055
0
2,000
0
4,880
0
5,194
0
7,914
0
4,923
0
9,770
0
6,936
0
11,826
0
7,160
0
12,795
0
3,082
0
13,942
16,079
16,079
0
27,390
0
19,150
0
29,519
20,988
20,988
0
35,971
0
23,427
0
40,205
0
040,205023,427035,971020,98820,98829,519019,150027,390016,07916,07913,94203,082012,79507,160011,82606,93609,77004,92307,91405,19404,88002,00004,05502,26504,88703,5800-880-2203,482018,15305,2203,97501,86113,540012,46311,922013,16307,308013,0007,725
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,894
0
0
0
0
0
0
0
0
0
0000000004,89400000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000-710-90-50-50-590-400-400-400-90-90-950-950-8850-5930-8110-778-77800000000000-2000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
17,374
0
17,384
17,506
0
24,418
0
18,606
0
19,430
0
19,811
0
17,116
0
5,094
0
4,885
0
4,853
0
4,854
0
3,496
0
4,835
0
4,888
21,076
4,889
0
4,885
0
4,823
24,705
4,822
30,924
4,812
26,341
4,829
32,674
4,815
38,193
4,845
52,110
4,818
56,934
25,583
65,443
-14,362
69,540
4,800
4,813
52,687
0
4,784
103,110
53,985
83,803
55,084
0
055,08483,80353,985103,1104,784052,6874,8134,80069,540-14,36265,44325,58356,9344,81852,1104,84538,1934,81532,6744,82926,3414,81230,9244,82224,7054,82304,88504,88921,0764,88804,83503,49604,85404,85304,88505,094017,116019,811019,430018,606024,418017,50617,384017,37400000000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue262,648
Cost of Revenue-30,565
Gross Profit232,083232,083
 
Operating Income (+$)
Gross Profit232,083
Operating Expense-176,409
Operating Income55,67455,674
 
Operating Expense (+$)
Research Development0
Selling General Administrative35,463
Selling And Marketing Expenses0
Operating Expense176,40935,463
 
Net Interest Income (+$)
Interest Income296
Interest Expense-1,217
Other Finance Cost-0
Net Interest Income-921
 
Pretax Income (+$)
Operating Income55,674
Net Interest Income-921
Other Non-Operating Income Expenses0
Income Before Tax (EBT)55,99155,357
EBIT - interestExpense = 56,010
55,060
41,422
Interest Expense1,217
Earnings Before Interest and Taxes (EBIT)57,22757,208
Earnings Before Interest and Taxes (EBITDA)78,107
 
After tax Income (+$)
Income Before Tax55,991
Tax Provision-14,855
Net Income From Continuing Ops41,13641,136
Net Income40,205
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses206,974
Total Other Income/Expenses Net317921
 

Technical Analysis of Clinica Baviera
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clinica Baviera. The general trend of Clinica Baviera is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clinica Baviera's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Clinica Baviera Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clinica Baviera.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 42.31 > 38.60 > 38.10.

Know someone who trades $CBAV? Share this with them.πŸ‘‡

Clinica Baviera Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clinica Baviera. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clinica Baviera Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clinica Baviera. The current macd is 1.36552457.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Clinica Baviera price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Clinica Baviera. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Clinica Baviera price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Clinica Baviera Daily Moving Average Convergence/Divergence (MACD) ChartClinica Baviera Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clinica Baviera. The current adx is 29.82.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Clinica Baviera shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Clinica Baviera Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clinica Baviera. The current sar is 41.63.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Clinica Baviera Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clinica Baviera. The current rsi is 65.35. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Clinica Baviera Daily Relative Strength Index (RSI) ChartClinica Baviera Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clinica Baviera. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clinica Baviera price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Clinica Baviera Daily Stochastic Oscillator ChartClinica Baviera Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clinica Baviera. The current cci is 94.38.

Clinica Baviera Daily Commodity Channel Index (CCI) ChartClinica Baviera Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clinica Baviera. The current cmo is 31.92.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Clinica Baviera Daily Chande Momentum Oscillator (CMO) ChartClinica Baviera Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clinica Baviera. The current willr is -16.94915254.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Clinica Baviera Daily Williams %R ChartClinica Baviera Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Clinica Baviera.

Clinica Baviera Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clinica Baviera. The current atr is 1.22010276.

Clinica Baviera Daily Average True Range (ATR) ChartClinica Baviera Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clinica Baviera. The current obv is -1,092,072.

Clinica Baviera Daily On-Balance Volume (OBV) ChartClinica Baviera Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clinica Baviera. The current mfi is 67.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Clinica Baviera Daily Money Flow Index (MFI) ChartClinica Baviera Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clinica Baviera.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Clinica Baviera Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clinica Baviera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.345
Ma 20Greater thanMa 5041.195
Ma 50Greater thanMa 10039.417
Ma 100Greater thanMa 20036.445
OpenGreater thanClose43.900
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Clinica Baviera with someone you think should read this too:
  • Are you bullish or bearish on Clinica Baviera? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clinica Baviera? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clinica Baviera

I send you an email if I find something interesting about Clinica Baviera.


Comments

How you think about this?

Leave a comment

Stay informed about Clinica Baviera.

Receive notifications about Clinica Baviera in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.